标题
Review to Understand the Crosstalk between Immunotherapy and Tumor Metabolism
作者
关键词
-
出版物
MOLECULES
Volume 28, Issue 2, Pages 862
出版商
MDPI AG
发表日期
2023-01-16
DOI
10.3390/molecules28020862
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metabolism of Amino Acids in Cancer
- (2021) Zhen Wei et al. Frontiers in Cell and Developmental Biology
- Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
- (2021) Joel Mintz et al. Vaccines
- Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
- (2021) Yongbo Yu et al. Cell Death Discovery
- Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models
- (2021) Kosaku Mimura et al. Gastric Cancer
- Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
- (2021) Xin Peng et al. Frontiers in Immunology
- Potential Antitumor Effects of 6-Gingerol in p53-Dependent Mitochondrial Apoptosis and Inhibition of Tumor Sphere Formation in Breast Cancer Cells
- (2021) Nipin Sp et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner
- (2021) Kailiang Zhao et al. MOLECULAR CANCER RESEARCH
- The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
- (2021) Bonnie L. Russell et al. Frontiers in Oncology
- Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review
- (2020) Bo Hu et al. CELL PROLIFERATION
- Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
- (2020) Laura Strauss et al. Science Immunology
- Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
- (2020) Alexander Duscha et al. CELL
- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
- (2020) Clélia Coutzac et al. Nature Communications
- Specific Polyunsaturated Fatty Acids Can Modulate in vitro Human moDC2s and Subsequent Th2 Cytokine Release
- (2020) Tamara Hoppenbrouwers et al. Frontiers in Immunology
- Immune checkpoint inhibitors in cancer immunotherapy
- (2020) Megan E. Himmel et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen
- (2020) Santosha A. Vardhana et al. NATURE IMMUNOLOGY
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- 6‐Gingerol suppresses tumor cell metastasis by increasing YAP ser127 phosphorylation in renal cell carcinoma
- (2020) Shan Xu et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Shaping of Dendritic Cell Function by the Metabolic Micro-Environment
- (2020) Eline Constance Brombacher et al. Frontiers in Endocrinology
- The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time’s a Charm
- (2020) Quentin Lecocq et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The glutaminase inhibitor CB-839 (Telaglenastat) enhances the anti-melanoma activity of T cell mediated immunotherapies.
- (2020) Sruthy Varghese et al. MOLECULAR CANCER THERAPEUTICS
- Enhancing anti-tumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
- (2019) K M Heinhuis et al. ANNALS OF ONCOLOGY
- Amino acid metabolism as drug target in autoimmune diseases
- (2019) Giada Mondanelli et al. AUTOIMMUNITY REVIEWS
- Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
- (2019) Howard West et al. LANCET ONCOLOGY
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma
- (2019) Henning Zelba et al. Cancer Immunology Research
- LBA8_PRKEYNOTE-522: Phase III study of pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC)
- (2019) P Schmid et al. ANNALS OF ONCOLOGY
- Lipid droplet‐dependent fatty acid metabolism controls the immune suppressive phenotype of tumor‐associated macrophages
- (2019) Hao Wu et al. EMBO Molecular Medicine
- Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
- (2019) Lawrence P. Andrews et al. NATURE IMMUNOLOGY
- Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis
- (2019) Ramy R. Saleh et al. Frontiers in Oncology
- Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression
- (2019) Xiaomi Li et al. EXPERIMENTAL CELL RESEARCH
- The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions
- (2018) Tong Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models
- (2018) Robert D. Leone et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer-associated fibroblasts in tumor microenvironment – Accomplices in tumor malignancy
- (2018) Zehuan Liao et al. CELLULAR IMMUNOLOGY
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The nutrient environment affects therapy
- (2018) Alexander Muir et al. SCIENCE
- Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
- (2018) Soumaya Kouidhi et al. Frontiers in Immunology
- Metabolic Stress in the Immune Function of T Cells, Macrophages and Dendritic Cells
- (2018) Charlotte Domblides et al. Cells
- Abstract 5629: Preclinical characterization of Sym023 a human anti-TIM3 antibody with a novel mechanism of action
- (2018) Trine Lindsted et al. CANCER RESEARCH
- The impact of metabolic reprogramming on dendritic cell function
- (2018) Livia de Lima Thomaz et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer
- (2018) T.J.N. Hermans et al. INTERNATIONAL JOURNAL OF CANCER
- Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
- (2018) Tara C. Mitchell et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).
- (2018) Luis G. Paz-Ares et al. JOURNAL OF CLINICAL ONCOLOGY
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Cancer immunotherapy: challenges and clinical applications
- (2018) An-Liang Xia et al. JOURNAL OF MEDICAL GENETICS
- TIM-3, a promising target for cancer immunotherapy
- (2018) Yayi He et al. OncoTargets and Therapy
- Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response
- (2018) Farhan Basit et al. Frontiers in Immunology
- Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells
- (2018) Li Jiang et al. Frontiers in Immunology
- Introduction to checkpoint inhibitors and cancer immunotherapy
- (2017) Arlene H. Sharpe IMMUNOLOGICAL REVIEWS
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- Review of cancer treatment with immune checkpoint inhibitors
- (2017) Christiane Thallinger et al. WIENER KLINISCHE WOCHENSCHRIFT
- TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis
- (2017) Yang Zhang et al. Oncotarget
- Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
- (2017) Eva M. Palsson-McDermott et al. Frontiers in Immunology
- Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
- (2017) Paulo C. Rodriguez et al. Frontiers in Immunology
- EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity
- (2017) Diana I. Albu et al. OncoImmunology
- The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study
- (2017) Alexandra W. Elias et al. Frontiers in Oncology
- Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
- (2017) Seema Gupta et al. Frontiers in Oncology
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
- (2016) Roger Geiger et al. CELL
- Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial
- (2016) Antonin Levy et al. EUROPEAN JOURNAL OF CANCER
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines
- (2016) Jingwei Liu et al. JOURNAL OF IMMUNOTHERAPY
- Arginine-Dual roles as an onconutrient and immunonutrient
- (2016) Vance L. Albaugh et al. JOURNAL OF SURGICAL ONCOLOGY
- The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia
- (2016) M Qorraj et al. LEUKEMIA
- Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
- (2016) Wei Yang et al. NATURE
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Pathological -synuclein transmission initiated by binding lymphocyte-activation gene 3
- (2016) X. Mao et al. SCIENCE
- Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
- (2016) J. Liu et al. Cancer Discovery
- Immunological Mechanisms Underneath the Efficacy of Cancer Therapy
- (2016) L. Galluzzi et al. Cancer Immunology Research
- Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk
- (2016) Jing Li et al. OncoImmunology
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
- (2015) Aiden Haghikia et al. IMMUNITY
- Notch Signaling Pathway Was Involved in Regulating Programmed Cell Death 1 Expression during Sepsis-Induced Immunosuppression
- (2015) Tingting Pan et al. MEDIATORS OF INFLAMMATION
- Curcumin and tumor immune-editing: resurrecting the immune system
- (2015) Sayantan Bose et al. Cell Division
- The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas
- (2015) Y. Komohara et al. Cancer Immunology Research
- Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity
- (2015) Yongkui Li et al. OncoImmunology
- Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues
- (2014) Tetsuya Honda et al. IMMUNITY
- Metabolic Reprogramming of Macrophages
- (2014) Alex J. Freemerman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway
- (2014) J Park et al. Mucosal Immunology
- Benefits of Vascular Normalization Are Dose and Time Dependent--Letter
- (2013) Y. Huang et al. CANCER RESEARCH
- Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
- (2012) Connie Jackaman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer
- (2012) M. Terme et al. CANCER RESEARCH
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
- (2012) Xin Gao et al. PLoS One
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search